Devises / HROW
HROW: Harrow Inc
39.00
USD
0.01
(0.03%)
Le taux de change de HROW a changé de 0.03% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 38.33 et à un maximum de 39.70.
Suivez la dynamique Harrow Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
HROW Nouvelles
- Harrow appoints Andrew R. Boll as president and names Randall E. Pollard chief accounting officer
- Harrow Baby Bonds Yield Review (NASDAQ:HROW)
- Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock
- Best Momentum Stock to Buy for August 15th
- Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet
- Harrow Stock's Ambitious Guidance Puts It In The Proving Ground (NASDAQ:HROW)
- Harrow Stock Eyes Relative Strength Rating Upgrade
- Harrow: Exciting Times In Store (NASDAQ:HROW)
- H.C. Wainwright raises Harrow Health stock price target on VEVYE growth
- Harrow, Inc. 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:HROW)
- Harrow, Inc. (HROW) Q2 2025 Earnings Call Transcript
- Harrow Health Q2 2025 slides: Mixed results amid strategic portfolio expansion
- Harrow Health earnings beat by $0.23, revenue fell short of estimates
- Barrick Gold, Roivant Sciences, Owens & Minor to report earnings Monday
- Harrow (HROW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Undercovered Dozen: Christian Dior, Coca-Cola, Trinity Capital, Amgen And More
- Harrow Health stock outlook strong as Cantor reiterates Overweight rating
- H.C. Wainwright reiterates Buy rating on Harrow Health stock at $60 target
- Harrow acquires exclusive US rights to Samsung Bioepis eye drugs
- Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
- Harrow's Internal $100 Price Target Is Ambitious, But Bloomberg Data Backs It Up (HROW)
- This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Harrow (NASDAQ:HROW), Janux Therapeutics (NASDAQ:JANX)
- Cantor Fitzgerald initiates Harrow Health stock with Overweight rating
- Harrow: Immense Upside Potential (NASDAQ:HROW)
Range quotidien
38.33
39.70
Range Annuel
20.85
59.23
- Clôture Précédente
- 38.99
- Ouverture
- 39.44
- Bid
- 39.00
- Ask
- 39.30
- Plus Bas
- 38.33
- Plus Haut
- 39.70
- Volume
- 928
- Changement quotidien
- 0.03%
- Changement Mensuel
- 25.60%
- Changement à 6 Mois
- 39.73%
- Changement Annuel
- -3.42%
31 août, dimanche